Title:Gileads Orphan Drug Designation for COVID19 Antiviral Raises Questions
Description:As Gilead begins to streamline the process for COVID19 patients to receive its experimental antiviral remdesivir on a wider basis the company also raised some eyebrows on Monday by obtaining an orphan drug designation for the potential COVID19 treatment.
Content:As Gilead begins to streamline the process for COVID19 patients to receive its experimental antiviral remdesivir on a wider basis the company also raised some eyebrows on Monday by obtaining an orphan drug designation for the potential COVID19 treatment.Or 3869 chars
